{
    "code": "52028674",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028674",
    "time": "2024-04-04 21:40:08",
    "許可證字號": "衛部藥輸字第028674號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/03\/13",
    "發證\/登錄日期": "113\/03\/13",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202867400",
    "中文品名": "愛息坦定&quot;山德士&quot;凍晶注射劑",
    "英文品名": "Azacitidine Sandoz Powder for Suspension for Injection",
    "適應症": "治療骨髓增生不良症候群高危險性的病人 (High Risk MDS)：頑固性貧血併有過量芽細胞 (RA with excess blasts, RAEB)、轉變中的頑固性貧血併有過量芽細胞 (RAEB in transformation, RAEB-T)、及慢性骨髓單核細胞性白血病 (chronic myelomonocytic leukemia, CMMoL)。 Azacitidine適用於治療65歲（含）以上、不適合接受HSCT或密集化學治療、且骨髓芽細胞比例>30%的AML成人病人（依據WHO分類）。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克type 1 玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥;",
    "監視期限": "",
    "主成分略述": "AZACITIDINE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "臺北市中山區民生東路3段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "MSN LABORATORIES PRIVATE LIMITED",
            "製造廠廠址": "Formulations Division, Unit-II, Sy. No.1277&amp;1319 to 1324, Nandigama (Village &amp; Mandal), Rangareddy (District)-509228,Telangana, India",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400500",
            "成分名稱": "AZACITIDINE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}